From the Sarcoma Foundation of America

Apply for a Grant

Sarcoma Foundation of America Research Grants


 

The Sarcoma Foundation of America has developed a program to provide grants to investigators interested in translational science sarcoma research. Funding of up to $50,000, allowing up to 10 percent indirect costs, is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.

In accordance with the mission of the Foundation, research involving the development of novel agents against sarcoma, or research that could potentially lead to the development of novel agents against sarcoma, is eligible for this funding.

Please refer to SFA's Grants FAQ for additional information.

Researchers must submit proposals electronically at proposalCENTRAL. First-time users will be required to register and complete a professional profile in order to apply for an SFA research grant. The SFA does not accept applications via e-mail.

For more information, visit the SFA website at https://www.curesarcoma.org/research/apply-for-a-grant/

Recommended Reading

Cardiac pleomorphic sarcoma after placement of Dacron graft
MDedge Hematology and Oncology
Chemotherapy, metabolic pathway may affect CAR T-cell potential
MDedge Hematology and Oncology
Updates of ongoing clinical trials
MDedge Hematology and Oncology
Cardiac pleomorphic sarcoma after placement of a Dacron graft
MDedge Hematology and Oncology
Onodera’s Prognostic Nutritional Index in soft tissue sarcoma patients as a predictor of wound complications
MDedge Hematology and Oncology
Tumor lysis syndrome in an adolescent with recurrence of abdominal rhabdomyosarcoma: A case report and literature review
MDedge Hematology and Oncology
Anti-PD-1 therapy with nivolumab in the treatment of metastatic malignant PEComa
MDedge Hematology and Oncology
Introducing The Sarcoma Journal—The Official Journal of the Sarcoma Foundation of America ™ : An Exciting Initiative in Peer-Reviewed Professional Education and Patient Advocacy
MDedge Hematology and Oncology
Dasatinib activity prominent in subset of GIST patients
MDedge Hematology and Oncology
The Sarcoma Foundation of America: Funding research, advocating for patients
MDedge Hematology and Oncology